Heart drug for blacks to be first pill sold for a specific race
15517
NEW ORLEANS A two-drug pill dramatically reduces deaths among blacks with heart failure. That landmark finding is expected to lead to government approval of the first medication marketed for a specific race.
506735
Wyeth launches a generic version of its own drug.
7320
TRENTON, NJ -- Two competing drug companies say they will work together on creating the first all-in-one AIDS pill. Experts are hailing the collaboration by Bristol-Myers Squibb and Gilead Sciences, which
27575
In an effort to make medication regimens easier for HIV-positive patients, two drug companies have announced plans to collaborate on the first all-in-one, one-a-day pill to treat the infection.
417734
Heart attack prevention has just taken another step with the US Food and Drug Administration&#39;s go-ahead for one of the nation&#39;s best-selling cholesterol
685744
The Medicines Company reacquires its own drug.
326752
Pfizer plans to ask for approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
142281
FDA advisory panel gives the nod to its heart drug.
303787
A once-daily pill that combines three drugs used to treat HIV received federal approval Wednesday, giving U.S. patients the first triple "cocktail" therapy that can be swallowed as a single dose.
134915
Two drug companies announced Monday they will collaborate on developing the first all-in-one, once-a-day pill to treat HIV infection - a long-sought goal that would make it
103386
A U.S. Food and Drug Administration preliminary analysis found a level of heart-attack risk with GlaxoSmithKline Plc's  diabetes drug Avandia similar to what was reported in a study earlier this week, the agency confirmed on Friday.
389285
In the first major trial to test a  drug only in blacks, an experimental drug developed by NitroMed  Inc. added to standard therapy helped heart failure patients  live significantly longer, researchers on Monday said.
589141
TONIGHT A MEDICAL BREAKTHROUGH FOR AFRICAN-AMERICANS WITH HIGH BLOOD PRESSURE. SCIENTISTS SAY A NEW DRUG SHOWS PROMISE OF NEARLY DOUBLING A PERSON&#39;S CHANCES OF SURVIVING HEART FAILURE.
409074
TRENTON, NJ A Bay Area company is one of two drug companies that will join forces to work on a breakthrough pill to treat HIV infection.
349515
WEDNESDAY, Feb. 7 (HealthDay News) -- The first non-prescription drug to treat obesity in American adults was approved Wednesday by the U.S. Food and Drug Administration.
513966
NDORI, Kenya -- Giving antiretroviral drugs to pregnant women has long been celebrated as one of the few successful tactics in the war against AIDS in Africa. A single pill for a woman in labor, followed by a sip of syrup for her newborn baby, cuts HIV transmission rates by more than half,...
386480
A German chemical and pharmaceutical company, Altana, said that it was selling its drugs business to Nycomed Holding of Denmark for 4.5 billion euros ($5.75 billion), following through on its intention to split the company and focus on its chemicals operation. Altana, based in Bad Homburg outside Frankfurt, is selling the business because it is too small to compete in the global drug industry. Altana said it would focus on its specialty chemicals business and keep its stock exchange listing. Nycomed, which focuses on prescription drugs for gastrointestinal and respiratory diseases, is owned by a consortium of private equity companies: the Blackstone Group, CSFB Private Equity, NIB Capital Private Equity and Nordic Capital. It will distribute AltanaÂs top-selling drug, the ulcer treatment Pantoprazol, in Nordic countries and Belgium.